| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aktis Oncology, Inc. (AKTS) has 7 insiders with recent SEC Form 4 filings, including 9 buys and 0 sells. AKTS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.86M | $91.55M | - | |
| 10% | 4.86M | $91.55M | - | |
| 10% | 1.66M | $31.20M | - | |
| 10% | 597.4K | $11.25M | - | |
| Dir | 19.6K | $369.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | Kim Helen Susan | Director, 10% Owner | Buy | 835,000 | $18.00 | $15,030,000.00 | +16.7% | -22.4% | - | |
| Jan 12, 2026 | Mpm Bioventures 2018, L.P.54 | 10% Owner | Buy | 1,112,777 | $18.00 | $20,029,986.00 | +12.2% | -22.4% | - | |
| Jan 12, 2026 | Foley Todd82 | Director, 10% Owner | Buy | 232,870 | $18.00 | $4,191,660.00 | +5.8% | -22.4% | - | |
| Jan 12, 2026 | Ecor1 Capital, LLC77 | Director | Buy | 2,222,222 | $18.00 | $39,999,996.00 | +89.8% | -22.4% | - | |
| Jan 12, 2026 | Gadicke Ansbert85 | 10% Owner | Buy | 1,112,777 | $18.00 | $20,029,986.00 | +12.2% | -22.4% | - | |
| Jan 12, 2026 | Vida Ventures Ii, LLC | 10% Owner | Buy | 835,000 | $18.00 | $15,030,000.00 | +16.7% | -22.4% | - |